KEY POINTS
  • Ark Invest's Cathie Wood said her firm is internally testing a fund that bets against major stocks in the benchmarks.
  • Wood said she wants to test the strategy on Ark's employees and did not say when the fund would be made available to retail investors.
  • Wood acknowledged it could be quite volatile but said that over the next five years it will be a huge winner as her innovation companies emerge and older bellwethers fade away.

In this article

Cathie Wood — known for her innovation ETFs that garnered billions in inflows during the pandemic — said Ark Invest is internally testing a fund that takes the strategy a step further by simultaneously betting against major stocks in the benchmarks that are being disrupted.

"We're testing out a portfolio, but it's really Ark on steroids," Wood told CNBC's "Squawk Box" on Wednesday. Wood said she wants to test the strategy on Ark's employees and did not say when the fund would be made available to retail investors.

In this article